Vascular & Endovascular Surgery »  Faculty »  Division Chief »  Michael S. Conte, M.D.

Michael S. Conte, M.D.

Professor and Chief,
Division of Vascular & Endovascular Surgery
Edwin J. Wylie, M.D. Chair in Vascular Surgery
Co-Director, UCSF Heart and Vascular Center
Co-Director, UCSF Center for Limb Preservation

Contact Information

Division of Vascular and Endovascular Surgery, UCSF
400 Parnassus Avenue, A-6110
San Francisco, CA 94143-0957
Phone: (415) 353-2357
Fax: (415) 353-2669

Education

  • 1978-82, Boston University, B.S., Biomedical Engineering
  • 1982-86, Albert Einstein College of Medicine, M.D., Medicine

Residencies

  • 1986-88, New York Hospital, Cornell Medical Center, Junior Resident, General Surgery
  • 1988-89, New York Hospital, Cornell Medical Center, Senior Resident, General Surgery
  • 1991-92, New York Hospital, Cornell Medical Center, Senior Resident, General Surgery
  • 1992-93, New York Hospital, Cornell Medical Center, Chief Resident, General Surgery

Fellowships

  • 1989-91, Brigham and Women's Hospital/Harvard, Research Fellow, Vascular Surgery
  • 1993-94, Harvard Medical School, Fellow, Vascular Surgery
  • 1993-94, Brigham and Women's Hospital, Fellow, Vascular Surgery

Board Certifications

  • American Board of Surgery, General Surgery, 1994
  • American Board of Surgry, Vascular Surgery, 1996

Program Affiliations

  • Cardiovascular Research Institute (CVRI)
  • UCSF Heart and Vascular Center

Biography

Dr. Michael Conte received his medical degree in 1986 at Albert Einstein College of Medicine. He completed his surgical residency at New York Hospital-Cornell Medical Center in 1993, which included a two year research fellowship at Brigham and Women's Hospital (BWH) and Massachusetts Institute of Technology in Boston. He completed his vascular surgery training in 1994 as the John Homans Fellow at BWH and Harvard Medical School (HMS), in Boston.

Dr. Conte was an Assistant Professor of Surgery at Yale University from 1994-1997, and a member of the Boyer Center for Molecular Medicine. Subsequently he returned to BWH where he served as Assistant Professor (1997-2001) and then Associate Professor (2001-2008 ) of Surgery at HMS. From 2002-2008, he was the Director of Vascular Surgical Research at BWH and from 2005-2008, he was Co-Director of the Clinical Trials Group at the Center for Surgery and Public Health (a joint initiative between HMS, BWH, and the Harvard School for Public Health).

Dr. Conte is a member of many professional organizations, including the Society for Vascular Surgery and the Society of University Surgeons. Dr. Conte has also been an invited lecturer for many regional, national, and international meetings and conferences. In 2006, he received the Distinguished Achievement Award from the New York Weill Cornell Medical Center Alumni Council. He is on the Editorial Board for Vascular and Endovascular Surgery, Vascular Medicine, Journal of Vascular Surgery, and Vascular. He has served as an Associate Editor for Circulation.

Awards & Honors

  • T1 Catalyst Award Finalist, UCSF Clinical and Translational Sciences Institute (CTSI), 2012
  • Best Doctors in America, Best Doctors, Inc., 2009
  • Best Doctors in Boston, Best Doctors, Inc., 2007
  • Distinguished Achievement Award, New York Weill Cornell Medical Center Alumni Council, 2006
  • Mentored Clinical Scientist Development Award, NHLBI/Lifeline, 1999
  • Fellowship Award, American Surgical Association Foundation, 1997-1999
  • Research Award, Lifeline Foundation, 1988
  • Alpha Omega Alpha, Medical Honor Society, 1986
  • Tau Beta Pi, National Engineering Honor Society, 1982
View all

Research Overview

Dr. Conte's clinical interests include diseases of the aorta and its major branches, aneurysms, carotid artery disease, and peripheral artery disease (PAD). He is particularly interested in diabetic vascular disease, and in complex revascularization to preserve limb function and prevent amputation in patients with advanced forms of PAD. He had led the largest multicenter clinical trial to date examining the outcomes of leg bypass surgery in patients with severe PAD and is nationally and internationally recognized for his leadership in this area.

Dr. Conte's research is focused on developing new molecular therapies to improve the long-term results of cardiovascular procedures. His translational research program includes basic laboratory investigations as well as prospective clinical trials to study the causes of failure of angioplasty and bypass surgery and develop new approaches to stratify patients at risk.

Clinical Trials

 

Publications

Most recent publications from a total of 160
  1. Chatterjee A, Sharma A, Chen M, Toy R, Mottola G, Conte MS. The Pro-Resolving Lipid Mediator Maresin 1 (MaR1) Attenuates Inflammatory Signaling Pathways in Vascular Smooth Muscle and Endothelial Cells. PLoS One. 2014; 9(11):e113480. View in PubMed
  2. Chong KC, Owens CD, Park M, Alley HF, Boscardin WJ, Conte MS, Gasper WJ, Grenon SM. Relationship between kidney disease and endothelial function in peripheral artery disease. J Vasc Surg. 2014 Dec; 60(6):1605-11. View in PubMed
  3. Subherwal S, Patel MR, Chiswell K, Tidemann-Miller BA, Jones WS, Conte MS, White CJ, Bhatt DL, Laird JR, Hiatt WR, Tasneem A, Califf RM. Clinical Trials in Peripheral Vascular Disease: Pipeline and Trial Designs: An Evaluation of the ClinicalTrials.gov Database. Circulation. 2014 Nov 11; 130(20):1812-9. View in PubMed
  4. Conte MS, Goodney PP. Regarding "Presentation, treatment, and outcome differences between men and women undergoing revascularization or amputation for lower extremity peripheral arterial disease". J Vasc Surg. 2014 Jul; 60(1):271-2. View in PubMed
  5. Nosova EV, Chong KC, Alley HF, Harris WS, Boscardin WJ, Conte MS, Owens CD, Grenon SM. Clinical correlates of red blood cell omega-3 fatty acid content in male veterans with peripheral arterial disease. J Vasc Surg. 2014 Jun 19. View in PubMed
  6. Hiramoto JS, Katz R, Weisman S, Conte M. Gender-specific risk factors for peripheral artery disease in a voluntary screening population. J Am Heart Assoc. 2014; 3(2):e000651. View in PubMed
  7. Walker JP, Hiramoto JS, Gasper WJ, Auyang P, Conte MS, Rapp JH, Lovett DH, Owens CD. Vitamin D deficiency is associated with mortality and adverse vascular access outcomes in patients with end-stage renal disease. J Vasc Surg. 2014 Jul; 60(1):176-83. View in PubMed
  8. Nosova EV, Yen P, Chong KC, Alley HF, Stock EO, Quinn A, Hellmann J, Conte MS, Owens CD, Spite M, Grenon SM. Short-term physical inactivity impairs vascular function. J Surg Res. 2014 Aug; 190(2):672-82. View in PubMed
  9. Owens CD, Gasper WJ, Walker JP, Alley HF, Conte MS, Grenon SM. Safety and feasibility of adjunctive dexamethasone infusion into the adventitia of the femoropopliteal artery following endovascular revascularization. J Vasc Surg. 2014 Apr; 59(4):1016-24. View in PubMed
  10. Oresanya L, Makam AN, Belkin M, Moneta GL, Conte MS. Factors associated with primary vein graft occlusion in a multicenter trial with mandated ultrasound surveillance. J Vasc Surg. 2014 Apr; 59(4):996-1002. View in PubMed
  11. View All Publications
Publications provided by UCSF Profiles, powered by CTSI at UCSF. View profile of Michael S. Conte, M.D.
Please note: UCSF Profiles publications are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact CTSI for help.

X